Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS)
Justyna Izdebska
1
,
Jacek Szaflik
1
Katedra i Klinika Okulistyki II Wydziału Lekarskiego Akademii Medycznej w Warszawie
Izdebska J, Szaflik J. Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS). Klinika Oczna / Acta Ophthalmologica Polonica. 2005;107(2):344-347.
APA
Izdebska, J., & Szaflik, J. (2005). Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS). Klinika Oczna / Acta Ophthalmologica Polonica, 107(2), 344-347.
Chicago
Izdebska, Justyna, and Jacek Szaflik. 2005. "Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS)". Klinika Oczna / Acta Ophthalmologica Polonica 107 (2): 344-347.
Harvard
Izdebska, J., and Szaflik, J. (2005). Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS). Klinika Oczna / Acta Ophthalmologica Polonica, 107(2), pp.344-347.
MLA
Izdebska, Justyna et al. "Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS)." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 107, no. 2, 2005, pp. 344-347.
Vancouver
Izdebska J, Szaflik J. Levofloxacin (Oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery – the study of the European Society of Cataract and Refractive Surgeons (ESCRS). Klinika Oczna / Acta Ophthalmologica Polonica. 2005;107(2):344-347.
Randomised multi-centre european clinical trial of antibiotic prophylaxis for endophthalmitis following cataract surgery – study has just begun in Poland. Poland is joining one of the largest prospective european clinical study of antibiotic prophylaxis and the largest in ophthalmology – the ESCRS endophthalmitis prophylaxis clinical trial. Up to 35 000 cataract patients are going to be recruited for this randomized, controlled, multi-centre study in 16 centres from 10 european countries. The goal is to reduce the incidence of endophthalmitis after cataract phacoemusification in Europe to less than 0.05% (less than 1 per 2 000 surgeries). The patients will be divided into four groups; different regimes of two antibiotics: cefuroxime injected intra-camerally and levofloxacine eye drops topically will be compared.
